Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Postpartum Dermatosis Management

Assessment and Immediate Management

  • The European Respiratory Society suggests that methylprednisolone 40 mg IM provides rapid systemic control for corticosteroid-responsive dermatosis 1, 2
  • The combination with antihistamines and topical mometasone is appropriate for symptomatic relief, particularly if PUPPP is in the differential, as recommended by the European Respiratory Journal 3, 4
  • Now that delivery has occurred, pregnancy-related concerns about systemic corticosteroids are eliminated, though breastfeeding considerations remain, according to the Annals of the Rheumatic Diseases 1, 2

Critical Next Steps

  • The American College of Rheumatology emphasizes that during postpartum, prednisone should be resumed at the previously effective dose, and the 2025 EULAR guidelines recommend that postpartum status removes the restriction on prednisone dose 1, 2
  • The EULAR guidelines also recommend that do not attempt further dose reduction until the diagnosis is confirmed and the patient achieves complete remission for at least 2-4 weeks 1, 2
  • If pemphigoid gestationis is confirmed, expect that postpartum flares often require higher doses and prolonged treatment, as suggested by the Annals of the Rheumatic Diseases 1, 2

Diagnostic Workup

  • PUPPP will show negative DIF, helping exclude autoimmune blistering disease, according to Praxis Medical Insights 4

Breastfeeding Considerations

  • The European Respiratory Journal recommends that prednisone/prednisolone is compatible with breastfeeding at doses ≤20 mg daily 3, 1
  • With prolonged treatment at higher maternal doses (>20 mg daily), advise delaying breastfeeding for 3-4 hours after the dose to minimize infant exposure, as suggested by the European Respiratory Journal 3

Common Pitfalls to Avoid

  • The Annals of the Rheumatic Diseases recommend that do not continue tapering corticosteroids without a confirmed diagnosis - the recurrence at 5 mg suggests either pemphigoid gestationis or inadequate dosing 1, 2
  • Praxis Medical Insights suggest that do not assume PUPPP will resolve quickly postpartum if it doesn't - persistent symptoms beyond 2 weeks postpartum strongly favor pemphigoid gestationis over PUPPP 4